For Industry

PDUFA Meetings

FDA periodically conducts meetings on the Prescription Drug User Fee Act (PDUFA) program. The current legislative authority for PDUFA (PDUFA IV), reauthorized in 2007 by the FDA Amendments Act (FDAAA), will expire in September 2012.  FDAAA requires that FDA hold public meetings and conduct discussions with both the regulated industry and stakeholder groups in developing recommendations for the next PDUFA program (FY2013-2017). 

This page contains information for both the public part of the PDUFA reauthorization process and the discussions FDA holds with industry and stakeholders.  

PDUFA Public Meeting October 24, 2011

PDUFA IV Public Meetings

Information about the three major public meetings that were held for PDUFA IV

Page Last Updated: 03/27/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.